Article Information
History
- March 10, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Anju Murayama1,2,*,
- Sae Kamamoto1,3,
- Kohki Yamada1,
- Divya Bhandari, MSH1,
- Iori Shoji1,
- Hanano Mamada1,
- Moe Kawashima1,
- Erika Yamashita1,
- Hiroaki Saito, MD, PhD4,
- Eiji Kusumi, MD5,
- Toyoaki Sawano, MD, PhD6,
- Binaya Sapkota7,
- Tetsuya Tanimoto, MD1,8 and
- Akihiko Ozaki, MD, PhD1,9
- 1Medical Governance Research Institute, Minato-ku, Tokyo, Japan
- 2Tohoku University School of Medicine, Sendai city, Miyagi, Japan
- 3Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan
- 4Department of Gastroenterology, Sendai Kosei Hospital, Sendai City, Miyagi, Japan
- 5Navitas Clinic Shinjuku, Shinjuku-ku, Tokyo, Japan
- 6Department of Surgery, Jyoban Hospital of Tokiwa Foundation, Iwaki City, Fukushima, Japan
- 7Nobel College Faculty of Health Sciences, affiliated to Pokhara University, Kathmandu, Nepal
- 8Department of Internal Medicine, Navitas Clinic, Tachikawa City, Tokyo, Japan
- 9Department of Breast Surgery, Jyoban Hospital of Tokiwa Foundation, Iwaki City, Fukushima, Japan
- ↵*Correspondence:
Anju Murayama, Medical Governance Research Institute, Minato-ku, Tokyo, 1087505, Japan, Telephone: 81-90-6321-6996, Email address: ange21tera{at}gmail.com
Posted March 10, 2022.
Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019
